Myovant Sciences Ltd (MYOV) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Myovant Sciences Ltd   (NYSE: MYOV)


Myovant Sciences Ltd 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Myovant Sciences Ltd 's ROA in the third quarter of 2023?
Myovant Sciences Ltd recorded a cumulative net loss of $-184 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -39.86%.

However, within the Healthcare sector 681 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2022 from 4611 to 5226.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter
Y / Y Total Assets Change -33.56 % -28.92 % -36.66 % -28.56 % -21.86 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -184 -190 -166 -206 -228
Return On Assets (TTM) -39.86 % -37.09 % -29.57 % -32.92 % -33.68 %
MYOV's Total Ranking # 5226 # 4611 # 4612 # 4667 # 5009
Total Assets (TTM) in million 397 478 455 514 598
Seq. Total Assets Change -16.85 % 4.87 % -11.41 % -13.99 % -11.05 %
Seq. Net Income Change - - - - -

MYOV's 5 Years Annual ROA >> Back to MYOV Management Effectiveness >> Compare MYOV ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 280
Sector # 682
Overall # 5066

Return On Assets Statistics
High Average Low
-29.25 %
-104.67 %
-201.2 %
(Jun 30 2022)   (Sep 30 2020)





Financial Statements
Myovant Sciences Ltd 's Assets $ 397 million MYOV's Balance sheet
Myovant Sciences Ltd 's Income $ -58 million Quarterly MYOV's Income Statement
MYOV's Income by Division See MYOV's Income by Division



Annual Return On Assets (Mar 31 2022)
FY 2022		 (Mar 31 2021)
FY 2021		 (Mar 31 2020)
FY 2020		 (Mar 31 2019)
FY 2019		 (Mar 31 2018)
FY 2018
Y / Y Total Assets Change -28.29 % 651.46 % -44.81 % 45.14 % -35.72 %
Total Assets in million 514 717 95 173 119
Y / Y Net Income Change - - - - -
Net Income in million -206 -255 -289 -274 -143
Annual Return On Assets -40.07 % -35.59 % -302.9 % -158.25 % -120.28 %

MYOV's 5 Years Annual ROA >> Back to MYOV Management Effectiveness >> Compare MYOV ROA to its Competitors



More Return On Assets Ratios
MYOV's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MYOV's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MYOV's Competitors
Subscribers only: Roa for Myovant Sciences Ltd 's Suppliers
Subscribers only: Return On Assets for MYOV's Customers

You may also want to know
MYOV's Roi MYOV's Inventory Turnover Ratio MYOV's Growth Rates MYOV's Dividend Comparisons
MYOV's Profitability Ratios MYOV's Asset Turnover Ratio MYOV's Dividend Growth
MYOV's Roe MYOV's Valuation Ratios MYOV's Financial Strength Ratios MYOV's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA

Date modified: 2026-09-26T07:31:36+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.